Summary: The efficacy and safety of combined ipilimumab and nivolumab versus ipilimumab in patients with Stage III/IV unresectable melanoma: A systematic review and meta-analysis.

Summary: OrienX010, an oncolytic virus, in patients with unresectable stage IIIC-IV melanoma: a phase Ib study.

Summary: For Whom the Bell Tolls? A Toll-Like Receptor 9 Agonist's Journey from Vaccine Adjuvant to Promising Agent in Anti-PD-1-Resistant Melanoma.

Summary: Photon-based High-dose Single-fraction Radiosurgery, an Effective Treatment Modality for Large and Posterior Uveal Melanoma.

Summary: Intestinal relapse of a cutaneous melanoma. Report of one case.

Summary: First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancers.

Summary: Recurrent brain metastases: the role of resection of in a comprehensive multidisciplinary treatment setting.

Summary: Phase IB study of ziv-aflibercept plus pembrolizumab in patients with advanced solid tumors.

Summary: A 41-Year-Old Woman with a Late Cerebral Metastasis 16 Years After an Initial Diagnosis of Cutaneous Melanoma.

Summary: Adjuvant PD-1 Blockade in Resected Melanoma: Is Preventing Recurrence Enough?

Summary: Effective Treatment of a Melanoma Patient with Hemophagocytic Lymphohistiocytosis after Nivolumab and Ipilimumab Combined Immunotherapy.

Summary: Insidious ocular surface lesion in an 81-year-old woman.